See the instruction manual for details

This product is a broad-spectrum semi-synthetic cephalosporin antibiotic. Its activity against penicillinase-producing Staphylococcus aureus, group A hemolytic streptococci, viridans streptococci and Staphylococcus epidermidis is the same as that of cefadroxil, and its antibacterial effect against non-enzyme-producing Staphylococcus aureus and pneumococci is 2 to 4 times stronger than that of cefadroxil. Its activity against Gram-negative bacilli, including Escherichia coli and Klebsiella pneumoniae, is stronger than that of cefadroxil, and is similar to that of cefadroxil. Its activity against Proteus mirabilis, Salmonella and Shigella is stronger than that of cefadroxil. 2.9 to 8 mg/L of this product can inhibit all Haemophilus influenzae, including strains resistant to ampicillin. Moraxella catarrhalis and Neisseria gonorrhoeae are very sensitive to this product. Indole-positive Proteus, Serratia, Acinetobacter and Pseudomonas aeruginosa are all resistant to this product. The mechanism of action of this product is to inhibit the synthesis of bacterial cell walls.

It has a broad spectrum of antibacterial activity against Gram-positive and Gram-negative bacteria, especially against Escherichia coli, Klebsiella, Haemophilus influenzae, Proteus and Bacteroides fragilis. Its mechanism of action is that it shows a strong affinity for penicillin-binding proteins, which are the usual action points of β-lactam antibiotics. It can inhibit cell wall synthesis and bind to peptidoglycan, inhibiting the binding of peptidoglycan to lipoprotein to promote bacteriolysis, and showing a strong bactericidal effect in a short time. This product shows antibacterial effect on bacteria during the proliferation period and the early stage of the stable period, and has a bactericidal effect at concentrations lower than the MIC, and lyses bacteria in a short time. The antibacterial effect in vivo is stronger than the prediction of the MIC.

The antibacterial property is similar to that of cefazolin, and it has good antibacterial effect on Staphylococcus, Streptococcus pyogenes, Streptococcus pneumoniae, Escherichia coli, Proteus mirabilis, Haemophilus influenzae, etc.

It has a wide range of antibacterial effects on both Gram-positive and Gram-negative bacteria, especially on Streptococcus and Pneumococcus among Gram-positive bacteria, and Gonorrhea, Borrelia, Escherichia coli, Serratia, Klebsiella, Proteus, and Haemophilus influenzae among Gram-negative bacteria. Since it is extremely stable to the β-lactamase produced by various bacteria, it also has excellent antibacterial properties against bacteria that produce β-lactamase. Its mechanism of action is mainly to prevent the synthesis of bacterial cell walls.